The present invention relates to compounds of the general form (I). Thepresent invention relates to new substituteddiazepino-indole derivatives of the general formula (I), and topharmaceutically acceptable salts thereof, as well as to pharmaceuticalcompositions comprising such compounds, to new intermediate thereof, as wellas to the use of such compounds in treatment or preventionof disorders associated with melanin-concentrating hormone receptor 1activity.